STAT
FEBRUARY 13, 2025
It’s no secret that life expectancy in the United States is among the lowest in the developed world and has been since long before the Covid-19 pandemic. The United States ranked 29 th in life expectancy at birth among peer nations in the Organization for Economic Cooperation and Development despite spending almost twice as much on clinical care per person as the average OECD nation.
European Pharmaceutical Review
FEBRUARY 13, 2025
New analysis by VTT Technical Research Centre of Finland has highlighted the EUs completely underestimated costs of the newly enforced Urban Wastewater Treatment Directive. Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
FEBRUARY 13, 2025
Panelists discuss how menopause marks a significant life transition, characterized by hormonal decline, reproduction cessation, and unique physiological changes requiring medical and emotional support. Health care professionals guide women through lifes reproductive stages, providing comprehensive health care from menarche to post menopause, focusing on individualized prevention of symptom management, and holistic well-being across hormonal transitions.
STAT
FEBRUARY 13, 2025
Bill Cassidy had a blunt question for Robert F. Kennedy Jr.: “What’s it going to be?” Cassidy was begging for the simplest possible concession from the man President Trump had chosen to serve as the nation’s top health care official. All he asked was that Kennedy declare “unequivocally” that vaccines do not cause autism.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The FDA Law Blog
FEBRUARY 13, 2025
By Lisa M. Baumhardt, Principal Medical Device Regulatory Expert FDA recently released its final guidance for Predetermined Change Control Plans (PCCPs) for Artificial Intelligence-Enabled Device Software Functions (AI-DSF). The final guidance hasnt changed much from the draft guidance with respect to the type of modifications FDA considers applicable for a PCCP and the required components of a PCCP (see our prior blog post on the draft guidance here ).
STAT
FEBRUARY 13, 2025
The National Institutes of Health and some VA regions are scouring existing grants using lists of flagged words, which include not just known trigger words for the Trump administration — trans, nonbinary, and diversity — but also “women” and “Covid.” The purpose of the lists remains unclear.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
FEBRUARY 13, 2025
Robert F. Kennedy Jr., the activist-turned-politician with a long history of embracing anti-scientific views, will become the next secretary of the Department of Health and Human Services. Senators voted 52-48 on Thursday to confirm Kennedy to the role. Republican Sen. Mitch McConnell (R-Ky.) voted against RFK Jr., as did all Democrats.
Drug Topics
FEBRUARY 13, 2025
What are some key strategies for keeping your pharmacy thriving in 2025?
STAT
FEBRUARY 13, 2025
WASHINGTON — Michael Lauer, deputy director of the National Institutes of Health’s extramural research, will leave the agency at the end of the week. News of Lauer’s departure comes one day after Lawrence Tabak, the agency’s longtime second-in-command, retired , a move several agency sources described as “sudden” and “abrupt.
Drug Topics
FEBRUARY 13, 2025
Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to discuss ultra-high-cost drugs and the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
FEBRUARY 13, 2025
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I apologize for this depressing, cynical newsletter. I still hope you read it. Why it’s so bleak out there My recent conversations with folks in the biotech investing world can only be described as bleak.
Drug Topics
FEBRUARY 13, 2025
Pharmacy industry experts gathered for a webinar detailing the upcoming trends expected to take shape in 2025.
PharmaVoice
FEBRUARY 13, 2025
The two companies will let their long-running contract expire this year, and drugmakers will need to decide which is the best platform for them in a changing marketplace.
Drug Topics
FEBRUARY 13, 2025
A discussion on the new nonopioid selective NaV1.8 pain signal inhibitor with Madison Irwin, PharmD, BCPS.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
FEBRUARY 13, 2025
The agency will now review the novel PCSK9 inhibitor for possible approval in patients with or at high risk of atherosclerotic cardiovascular disease.
Fierce Healthcare
FEBRUARY 13, 2025
Immediately following Senate confirmation, Robert F. Kennedy Jr. has been named chair of the Make America Healthy Again Commission, which will be focused on chronic disease and transparency in medical research.
Pharmacy Times
FEBRUARY 13, 2025
The expanding role of real-world evidence in regulatory and health technology assessment (HTA) decision-making highlights its growing acceptance for supplementing clinical trial data, addressing evidence gaps, and informing treatment value, despite challenges in data quality, accessibility, and regulatory compliance.
PhRMA
FEBRUARY 13, 2025
PhRMA recently submitted comments in response to the Centers for Medicare & Medicaid Services (CMS) proposed rule which would extend coverage of anti-obesity medicines (AOMs) in Medicare Part D and state Medicaid plans. Currently, AOMs are excluded from Medicare Part D coverage and optional in state Medicaid programs, when used specifically for the treatment of obesity, because they’re labeled as “agents used for weight loss.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
FEBRUARY 13, 2025
Panelists discuss how menopause marks a significant life transition, characterized by hormonal decline, reproduction cessation, and unique physiological changes requiring medical and emotional support. Health care professionals guide women through lifes reproductive stages, providing comprehensive health care from menarche to post menopause, focusing on individualized prevention of symptom management, and holistic well-being across hormonal transitions.
Fierce Healthcare
FEBRUARY 13, 2025
The full Senate voted 52-48 today to confirm Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Kennedy committed to work closely with the top Republican physician Bill Cassidy, who aims to keep Kennedy honest on maintaining public health infrastructure.
Pharmacy Times
FEBRUARY 13, 2025
Andrew Lin, PharmD, BCOP, discusses his pharmacist-led study examining the association between early tacrolimus levels and outcomes post-allogeneic hematopoietic cell transplantation.
Fierce Healthcare
FEBRUARY 13, 2025
Nationwide median operating margin for rural hospitals sits at 1%, though that metric is negative in 16 states and worsened in Medicaid non-expansion states.
Pharmacy Times
FEBRUARY 13, 2025
Currently, the Cadherin-6 targeting antibody-drug conjugate is undergoing evaluation in a phase 1a/1b clinical trial.
Fierce Healthcare
FEBRUARY 13, 2025
Hims & Hers hit the bullseye with its Super Bowl adit sparked a lot of attention from consumers for its brand and weight loss products. But the controversial ad also caught the attention of the pharma industry and lawmakers, who lashed the company for "deceptive" advertising.
Pharmacy Times
FEBRUARY 13, 2025
The combination greatly improved progression-free survival and overall survival.
pharmaphorum
FEBRUARY 13, 2025
The US Senate today confirmed Robert F Kennedy Jr as Health and Human Services Secretary, after a vote that largely followed party lines.
Pharmacy Times
FEBRUARY 13, 2025
Diabetes management through insulin could play a significant role in preventing antibiotic resistance.
STAT
FEBRUARY 13, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! A friend and former journalism school classmate wrote a beautiful essay in the New York Times yesterday about grieving with Paddington (the bear and film franchise). I can’t recommend it enough.
Pharmacy Times
FEBRUARY 13, 2025
Talazoparib in combination with enzalutamide yielded significant improvements in radiographic progression-free survival and overall survival.
pharmaphorum
FEBRUARY 13, 2025
Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder.
Pharmacy Times
FEBRUARY 13, 2025
Building on a previously granted orphan drug designation, the latest FDA action for amezalpat puts the drug in a position for regulatory approval.
pharmaphorum
FEBRUARY 13, 2025
Another AI drug discovery venture has emerged from the Google DeepMind team, Latent Labs, with $50m in funding for its protein design platform.
Pharmacy Times
FEBRUARY 13, 2025
This surgery can be significant in reducing the long-term risk of adverse outcomes and decompensation in cirrhosis related to metabolic dysfunction-associated steatohepatitis (MASH).
Expert insights. Personalized for you.
Let's personalize your content